文献速递病毒性肝炎艾滋病与性传播感染

丙型肝炎围产期与产后照护级联的缺口:孕期治疗的理由

Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy.
PubMed 文献 · Clin Infect Dis · 2026-01-01

RNA阳性后1、2、5年治疗率分别为1.1%、2.5%、5.2%,最终51.8%启动治疗、30.5%获持续病毒学应答;确诊慢性HCV者中47.5%存在治疗机会缺失。

要点

  • RNA阳性后5年内启动治疗者不足10%,围产期照护级联缺口显著。
  • 确诊慢性HCV的孕妇中47.5%存在治疗机会缺失,19.2%有多次缺失。
  • 妊娠次数多及2012年前确诊与治疗机会缺失风险升高相关。

核心结论

  • 尽管已获诊断,RNA阳性后5年内启动治疗者不足10%,且多次妊娠发生在治疗之前,造成反复暴露。
  • 需额外努力确保妊娠期或产后建立照护联系并启动治疗。

研究设计与样本

  • 加拿大安大略省回顾性队列研究,将HCV检测记录的孕妇与健康行政数据链接。
  • 采用Andersen-Gill模型分析治疗机会缺失(治疗前或无治疗时发生的妊娠)与启动治疗的预测因素。

主要发现

  • RNA阳性后1、2、5年治疗率分别为1.1%、2.5%、5.2%。
  • 最终3861人(51.8%)启动治疗,2277人(30.5%)达到持续病毒学应答。
  • 确诊慢性HCV者中47.5%(n=3025)存在治疗机会缺失,19.2%(n=1221)有多次缺失。
  • 妊娠次数多和2012年前确诊与治疗机会缺失可能性升高相关;物质使用障碍、HIV和慢性病诊断与可能性降低相关。

临床怎么用

  • 围产期HCV管理应关注RNA检测后的照护衔接,减少治疗前的反复妊娠暴露。
  • 对多次妊娠及2012年前确诊者应加强治疗机会识别与产后链接照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis C virus (HCV) infections have increased among younger populations, including pregnant people. While universal screening guidelines have improved case-finding, studies suggest low postpartum linkage-to-care rates. Better understanding of the peripartum HCV care cascade at the population level is needed to inform optimal management, including the role of treatment in pregnancy. METHODS: A retrospective cohort study linking pregnant individuals with HCV test records to health administrative data in Ontario, Canada. We examined the HCV care continuum, including during subsequent pregnancies. We used Andersen-Gill models to examine predictors of missed opportunities for treatment, defined as pregnancies occurring before/in absence of treatment, and initiating treatment. RESULTS: From 2003 to 2021, we identified 42 797 pregnancies in 16 888 people who tested HCV antibody-positive between 1999 and 2021. Of antibody-positive individuals, 14 538 (86.1%) had RNA testing and 7457 (51.3%) tested RNA-positive. Treatment uptake was 1.1%, 2.5%, and 5.2% at 1, 2, and 5 years after RNA positivity. Ultimately, 3861 (51.8%) initiated treatment and 2277 (30.5%) demonstrated sustained virologic response. Among those with confirmed chronic HCV, 47.5% (n = 3025) experienced a missed opportunity for treatment, with 19.2% (n = 1221) having multiple missed opportunities. Numbers of pregnancies and diagnosis year pre-2012 were associated with higher likelihood of a missed opportunity for treatment, while diagnoses of substance use disorder, HIV, and chronic disease were associated with lower likelihood. CONCLUSIONS: Despite diagnosis, <10% initiated treatment within 5 years of RNA positivity and multiple pregnancies occurred before treatment, resulting in repeated exposures. Additional efforts will be required to ensure linkage-to-care and treatment either during pregnancy or postpartum.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mendlowitz AB, Flemming JA, Kushner T, et al. Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy. Clin Infect Dis. 2026. PMID: 41363839. doi:10.1093/cid/ciaf578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。